Roupen Odabashian: Would you whole-body MRIs to screen for cancer?

Roupen Odabashian shared a post by Delta: HealthTech Innovators on LinkedIn:

“Considering the high cost of whole-body MRIs and our limited knowledge of using this test for cancer screening, would you use it to screen for cancer? But also the upside is that it can detect cancer in the early stage where a cure is possible.”

Quoting Delta: HealthTech Innovators’ post:

“Whole-body MRI is trending right now. Many people are considering it for cancer screening, but it can also increase the risk of invasive procedures like biopsies and is currently costly. Would you consider doing a full-body MRI if it could help detect cancer earlier?”

Source: Roupen Odabashian/LinkedIn and Delta: HealthTech Innovators/LinkedIn

Dr. Roupen Odabashian is an accomplished Internal Medicine Physician and Hematology/Oncology Fellow with a profound commitment to advancing healthcare through clinical practice, research, and technology. Currently based at the prestigious Karmanos Cancer Institute, Dr. Odabashian is actively involved in pioneering cancer treatments and conducting clinical research.

In addition to his clinical work, Dr. Odabashian is a multifaceted healthcare professional. He hosts podcast at OncoDaily, engaging with leading experts in oncology to share valuable insights with the medical community.